Healthcare -
Biotechnology - NASDAQ - US
$ 7.37
3.08 %
$ 365 M
Market Cap
-1.47
P/E
RGNX - OPERATING INCOME
Operating Income RGNX - REGENXBIO Inc.
-268 M
LAST VALUE
-63.59%
2 YEAR CAGR
-32.24%
5 YEAR CAGR
-49.60%
10 YEAR CAGR